Theranos Overview
- Founded
-
2003
- Status
-
Out of Business
- Employees
-
700
- Latest Deal Type
-
Liquidation
Theranos General Information
Description
Developer of bio-monitoring systems designed to facilitate small-sample collections, testing, and rapid communication of diagnostic information. The company's system creates an integrated infrastructure for real-time testing, decision making, and individualized therapy, thereby enabling laboratories to process early detection and intervention.
Contact Information
Website
www.theranos.com
Formerly Known As
RealTime Cures
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Primary Office
- 1701 Page Mill Road
- Palo Alto, CA 94304
- United States
Theranos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Bankruptcy: Liquidation | 05-Sep-2018 | 00.000 | Completed | Bankruptcy: Liquidation | ||
| 10. Debt - General | 23-Dec-2017 | 00000 | 00.000 | Completed | Generating Revenue | |
| 9. Secondary Transaction - Private | 27-Mar-2017 | 00000 | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series C3) | 01-Oct-2015 | 00000 | 000.00 | Cancelled | Generating Revenue | |
| 7. Later Stage VC | 00000 | 00000 | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series C2) | 04-Feb-2014 | 00000 | 00000 | 00.00 | Completed | Generating Revenue |
| 5. Later Stage VC (Series C1) | 28-Mar-2013 | 0000 | 00000 | 00.000 | Completed | Generating Revenue |
| 4. Later Stage VC (Series C1) | 08-Jul-2010 | 0000 | 000.00 | 00.000 | Completed | Generating Revenue |
| 3. Later Stage VC (Series C) | 15-Nov-2006 | $32.4M | $48.4M | 00000 | Completed | Startup |
| 2. Early Stage VC (Series B) | 16-Feb-2006 | $9.1M | $16M | 0000 | Completed | Startup |
Theranos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C3 | 00,000,000 | 00.000000 | 000 | 000 | 00 | 000 | 0.000 | |
| Series C2 | 00,000,000 | 00.000000 | 000 | 000 | 00 | 000 | 00.000 | |
| Series C1 | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 0.000 | |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series B | 54,162,965 | $0.000100 | $0.18 | $0.18 | 1x | $0.18 | 10.03% | |
| Series A | 46,320,045 | $0.000100 | $0.15 | $0.15 | 1x | $0.15 | 8.58% |
Theranos Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-monitoring systems designed to facilitate small-sample collections, testing, and rapid communication of
Medical Supplies
Palo Alto, CA
700
As of 2022
00.000
000000000000
00.000
000 00
ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
0000000000 000000000
Fremont, CA
00
As of 0000
00000000000
000000
llamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
0000000000 000000000
Shoreview, MN
00
As of 0000
000.00
000000000 -
000.00
Add Comparison
Theranos Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ARK Diagnostics | Formerly VC-backed | Fremont, CA | 00 | 00000000000 | ||
| 000000 00 | Venture Capital-Backed | Shoreview, MN | 00 | 000.00 | 000000000 - | 000.00 |
| 000000 | Formerly VC-backed | Union City, CA | 000 | 000.00 | 000000&0 | 000.00 |
| 00000000 000000 | Formerly VC-backed | York, United Kingdom | 000 | 000.00 | 00000000 | 000.00 |
| 000000 000000 | Venture Capital-Backed | Austin, TX | 000 | 00000 | 00000000000 | 00000 |
Theranos Patents
Theranos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200176154-A1 | Methods and compositions for superparamagnetic particles for nucleic acid extraction | Pending | 01-Jun-2017 | 0000000000 | |
| US-20170189899-A1 | Multi-piece fluid transfer tip | Abandoned | 30-Dec-2015 | 0000000000 | 0 |
| CA-2951696-A1 | Devices and methods for use with a sample container | Pending | 13-Jun-2014 | 00000000 | |
| EP-3068305-A1 | Methods and systems for a sample collection device with a novelty exterior | Withdrawn | 11-Nov-2013 | 000000000000 | |
| US-20160354021-A1 | Methods and systems for a sample collection device with a novelty exterior | Abandoned | 11-Nov-2013 | A61B5/150839 | 00 |
Theranos Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
